Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors-Reference-Cited by-同舟云学术

Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors

Published:2023-06 Issue:3 Volume:5 Page:392-401
ISSN:2666-0873
Container-title:JACC: CardioOncology
language:en
Short-container-title:JACC: CardioOncology

Author:

Singh Purnima^ORCID,Crossman David K.,Zhou Liting,Wang Xuexia,Sharafeldin Noha,Hageman Lindsey,Blanco Javier G.,Burridge Paul W.^ORCID,Armenian Saro H.,Balis Frank M.,Hawkins Douglas S.,Keller Frank G.,Hudson Melissa M.,Neglia Joseph P.,Ritchey A. Kim,Ginsberg Jill P.,Landier Wendy,Bhatia Smita

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Oncology

Reference49 articles.

1. Reduction in late mortality among 5-year survivors of childhood cancer;Armstrong;N Engl J Med,2016

2. Genetics of anthracycline cardiomyopathy in cancer survivors: JACC: CardioOncology state-of-the-art review;Bhatia;J Am Coll Cardiol CardioOnc,2020

3. CELF4 variant and anthracycline-related cardiomyopathy: a Children’s Oncology Group genome-wide association study;Wang;J Clin Oncol,2016

4. Identification of drug transporter genomic variants and inhibitors that protect against doxorubicin-induced cardiotoxicity;Magdy;Circulation,2022

5. Candidate gene association studies of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis;Leong;Sci Rep,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silencing LCN2 enhances RSL3-induced ferroptosis in T cell acute lymphoblastic leukemia;Gene;2023-08

2. Genetic Predisposition to Cardiovascular Disease in Patients With Cancer;JACC: CardioOncology;2023-06

3. Prevalence of Diastolic Dysfunction in Adult Survivors of Childhood Cancer;JACC: CardioOncology;2023-06

4. Anthracyclines and Biomarkers of Myocardial Injury;JACC: CardioOncology;2023-06

5. The Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Anthracycline-Treated Patients With Cancer;JACC: CardioOncology;2023-06